Nanoscope Therapeutics Inc.
PrivateLast Round
Grant
Sep 14, 2021
Total Funding Raised
$14.83M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Nanoscope Therapeutics Inc. is a biotechnology company developing gene-agnostic, vision-restoring optogenetic therapies for patients blinded by retinal degenerative diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nanoscope Therapeutics Inc. Comparables
Compare Nanoscope Therapeutics Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Ray Therapeutics | 86% | |
| SparingVision | 85% | |
| Gensight Biologics | 84% |
Nanoscope Therapeutics Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Sep 14, 2021 | ||||
| Series A | Jul 21, 2020 | ||||
| Grant | Jun 22, 2020 |
Nanoscope Therapeutics Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NIH RADx | Grant |
| AG Collective Capital | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors increased 62% MoM, reaching 7.5K.
- Apr 23, 2026
Attending ARVO 2026 Annual Meeting and Eyecelerator @ ARVO 2026.
Recent news
Latest coverage and updates
- attends_eventSep 23, 2026
Nanoscope Therapeutics, Inc. will attend event 26th Euretina Congress on Oct 1st '26.
- attends_eventSep 23, 2026
Nanoscope Therapeutics, Inc. will attend event 26th Euretina Congress and Ophthalmology Futures Forums Retina Forum on Oct 1st '26.
- attends_eventSep 15, 2026
Nanoscope Therapeutics, Inc. will attend event 59th Annual Scientific Meeting of the Retina Society on Sep 23rd '26.
Nanoscope Therapeutics Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Nanoscope Therapeutics Inc.'s valuation, stock price, and market status.
Is Nanoscope Therapeutics Inc. a public or private company?
Nanoscope Therapeutics Inc. is a private company.
What is the current stock price of Nanoscope Therapeutics Inc.?
Nanoscope Therapeutics Inc. is a private company with no public stock price. No recent secondary market data is available.
How much is Nanoscope Therapeutics Inc. worth (valuation)?
Valuation information for Nanoscope Therapeutics Inc. is not publicly available.
Can I buy Nanoscope Therapeutics Inc. stock?
Nanoscope Therapeutics Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Nanoscope Therapeutics Inc.'s last funding round?
Nanoscope Therapeutics Inc.'s most recent funding round was Grant on September 14, 2021.
Who are the main investors in Nanoscope Therapeutics Inc.?
Key investors in Nanoscope Therapeutics Inc. include NIH RADx, AG Collective Capital.
Will Nanoscope Therapeutics Inc. IPO soon?
No public IPO plans have been announced for Nanoscope Therapeutics Inc..
How can I track Nanoscope Therapeutics Inc. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Nanoscope Therapeutics Inc.'s secondary market activity and sign up for updates.